What is the difference between domestic and imported senfolo (pramipexole hydrochloride tablets)?

Senfuluo has the characteristics of improving dyskinesia, relieving non-motor symptoms such as depression, protecting nerves, delaying the progress of the disease and improving the quality of life in the treatment of Parkinson's disease. So, is Senfolo (pramipexole hydrochloride tablets) made in China or imported? What is the difference? Senfolo (pramipexole) is a new generation of non-ergot dopamine receptor agonist, which is an imported drug. Developed and produced by Boehringer Ingerham Company in Germany, it was first approved for the treatment of primary Parkinson's disease in 1997. Can be used alone or in combination with levodopa, and can be used in the whole stage of the disease until the late stage of Parkinson's disease. It is the first-line drug recommended by the treatment guidelines for Parkinson's disease at home and abroad. Studies have shown that Xianfurol can obviously improve the motor symptoms of patients with early and late Parkinson's disease. In addition to improving the motor symptoms of Parkinson's disease, clinical research results show that Senfrow can also improve the depressive symptoms related to Parkinson's disease, which is a common non-motor symptom of Parkinson's disease patients. The difference between imported drugs and domestic drugs mainly lies in price and efficacy, mainly because most imported drugs are "original research", while domestic drugs are mostly generic drugs. Although the price is relatively cheap, it is still high relative to its pharmaceutical cost. Relatively speaking, the drugs imported by most patients have better purity and more reliable data in all aspects, and they are willing to accept them even if the price is high. In fact, domestic manufacturers' good drugs are also good, but the current situation of "big but not strong" in China's pharmaceutical industry is also a big weakness of domestic drugs, and the patent fees of imported drugs can make foreign pharmaceutical companies make a lot of money. Of course, patients can choose according to their own situation.